FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt thumbnail

FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt

Shkreli’s latest company, Druglike, may run afoul of his lifetime pharma ban…
Read More

Posted in Uncategorized.